حدد سهمًا أو عملة مشفرة في شريط البحث للحصول على ملخص
Win-Partners Co Ltd
3183WIN-Partners Co., Ltd., through its subsidiaries, distributes medical devices to medical institutions primarily in Japan. The company offers percutaneous transluminal coronary angioplasty balloon catheters, drug-eluting stents, and intravascular ultrasound catheters; pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters; and stent grafts, transcatheter heart valves, and mechanical heart valves. It also provides peripheral vascular stents, carotid artery stents, and embolic coils; and insulin pumps, as well as continuous glucose monitoring, and computed tomography equipment. WIN-Partners Co., Ltd. was founded in 1973 and is headquartered in Tokyo, Japan. Address: Kyobashi Edogrand, Tokyo, Japan, 104-0031
Analytics
سعر الهدف في وول ستريت
–نسبة السعر إلى الأرباح
17.72العائد الربحي
3.90 %السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
الشخصيات الرئيسية 3183
تحليلات الأرباح 3183
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–نمو الأرباح على مدى 5 سنوات
56.00 %النمو المستمر
9 سنينمعدل الدفع 5 سنوات في المتوسط
50.00 %تاريخ الأرباح 3183
تقييم الأسهم 3183
المالية 3183
نتائج | 2019 | ديناميات |